New HIV medicine introduced for kids which tastes like strawberries!

By 2 weeks ago

Indian pharmaceutical company Cipla, in an attempt to save thousands of children from HIV AIDS, has introduced a new drug called Quadrimune.

Cipla developed this revolutionary new drug in partnership with the not-for-profit Drugs for Neglected Diseases initiative (DNDi) in a bid to secure the lives of thousands of children from the deadly wrath of HIV AIDS. The medicine which can be expected to change the future of the children who are prone to fall into the pit of the disease is claimed to be easy to consume by children and even toddlers! It’s going to be released in the flavor strawberry and to add to the already appealing solution to the problem of HIV AIDS among the innocent children, the medicine is not even that expensive!

It’s a heartbreaking fact that around 1.8 million children are living with HIV at the moment and nearly 300 lose the battle every year. Only 54% of the children get the chance to get treated and receive a little relief from the grip of the disease. Medical treatments do exist already exist for babies living with HIV but unfortunately, they tend to revolve around bitter-tasting pills and syrups with 40% alcohol in them. In addition, they are to be kept in a cool environment like in the refrigerator, which is not possible in areas with warm temperatures and a lack of resources like in Africa.

Cipla has very conveniently designed this new medicine to eliminate the short comings of the previously launched medicines, at a very reasonable price. The medicine introduced is said to be strawberry flavored which is much more appealing to the babies and it has been designed with a combination of four heat-stable antiretrovirals (ARVs), which means there’s no need for refrigeration for the drug.

Quadrimune comes in the form of an easy to swallow granule like a capsule, which are nearly as big ass sugar grains. It is being reviewed by the US Food and Drug Administration (FDA) and will probably receive approval by next year. The drug has a lot of hopes attached to it and will probably make the treatment of HIV more accessible to many more children and save many more lives.